BMRN
Price
$54.77
Change
+$0.41 (+0.75%)
Updated
Sep 18, 12:11 PM (EDT)
Capitalization
10.36B
34 days until earnings call
FOLD
Price
$8.43
Change
+$0.46 (+5.77%)
Updated
Sep 18, 12:36 PM (EDT)
Capitalization
2.47B
48 days until earnings call
Interact to see
Advertisement

BMRN vs FOLD

Header iconBMRN vs FOLD Comparison
Open Charts BMRN vs FOLDBanner chart's image
BioMarin Pharmaceutical
Price$54.77
Change+$0.41 (+0.75%)
Volume$200
Capitalization10.36B
Amicus Therapeutics
Price$8.43
Change+$0.46 (+5.77%)
Volume$11.14K
Capitalization2.47B
BMRN vs FOLD Comparison Chart in %
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. FOLD commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and FOLD is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (BMRN: $54.39 vs. FOLD: $7.97)
Brand notoriety: BMRN and FOLD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 130% vs. FOLD: 124%
Market capitalization -- BMRN: $10.36B vs. FOLD: $2.47B
BMRN [@Biotechnology] is valued at $10.36B. FOLD’s [@Biotechnology] market capitalization is $2.47B. The market cap for tickers in the [@Biotechnology] industry ranges from $100.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileFOLD’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • FOLD’s FA Score: 0 green, 5 red.
According to our system of comparison, FOLD is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 3 TA indicator(s) are bullish while FOLD’s TA Score has 2 bullish TA indicator(s).

  • BMRN’s TA Score: 3 bullish, 6 bearish.
  • FOLD’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than FOLD.

Price Growth

BMRN (@Biotechnology) experienced а -0.20% price change this week, while FOLD (@Biotechnology) price change was +0.38% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.28%. For the same industry, the average monthly price growth was +6.08%, and the average quarterly price growth was +34.58%.

Reported Earning Dates

BMRN is expected to report earnings on Oct 22, 2025.

FOLD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.28% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.4B) has a higher market cap than FOLD($2.47B). FOLD YTD gains are higher at: -15.393 vs. BMRN (-17.252). BMRN has higher annual earnings (EBITDA): 934M vs. FOLD (33.1M). BMRN has more cash in the bank: 1.43B vs. FOLD (231M). FOLD has less debt than BMRN: FOLD (443M) vs BMRN (604M). BMRN has higher revenues than FOLD: BMRN (3.06B) vs FOLD (571M).
BMRNFOLDBMRN / FOLD
Capitalization10.4B2.47B421%
EBITDA934M33.1M2,822%
Gain YTD-17.252-15.393112%
P/E Ratio16.04N/A-
Revenue3.06B571M537%
Total Cash1.43B231M620%
Total Debt604M443M136%
FUNDAMENTALS RATINGS
BMRN vs FOLD: Fundamental Ratings
BMRN
FOLD
OUTLOOK RATING
1..100
5970
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
63
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
6596
PRICE GROWTH RATING
1..100
8250
P/E GROWTH RATING
1..100
98100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (52) in the Biotechnology industry is in the same range as FOLD (63). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

BMRN's SMR Rating (65) in the Biotechnology industry is in the same range as FOLD (96). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

FOLD's Price Growth Rating (50) in the Biotechnology industry is in the same range as BMRN (82). This means that FOLD’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (98) in the Biotechnology industry is in the same range as FOLD (100). This means that BMRN’s stock grew similarly to FOLD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNFOLD
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
65%
Bearish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
73%
N/A
MACD
ODDS (%)
Bearish Trend 1 day ago
62%
Bearish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
64%
Bullish Trend 1 day ago
71%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
61%
Bullish Trend 1 day ago
73%
Advances
ODDS (%)
Bullish Trend 1 day ago
60%
Bullish Trend 8 days ago
70%
Declines
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
76%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
76%
Aroon
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FOLD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
FOREX / NAMEPrice $Chg $Chg %
AUDCHF0.53N/A
N/A
Australian Dollar - Switzerland Franc
CHFCAD1.75N/A
N/A
Switzerland Franc - Canadian Dollar
EURJPY173.80N/A
N/A
Euro - Japan Yen
JPYCNY0.05N/A
N/A
Japan Yen - China Yuan
OIH256.41-3.80
-1.46%
VanEck Oil Services ETF

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with AXON. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+0.83%
AXON - BMRN
42%
Loosely correlated
+0.15%
IBO - BMRN
42%
Loosely correlated
-7.38%
FGEN - BMRN
41%
Loosely correlated
-3.21%
TECH - BMRN
41%
Loosely correlated
-0.50%
SYRE - BMRN
40%
Loosely correlated
+1.82%
More

FOLD and

Correlation & Price change

A.I.dvisor indicates that over the last year, FOLD has been loosely correlated with VCYT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if FOLD jumps, then VCYT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOLD
1D Price
Change %
FOLD100%
-0.50%
VCYT - FOLD
43%
Loosely correlated
-1.36%
ATXS - FOLD
42%
Loosely correlated
+1.79%
IRON - FOLD
40%
Loosely correlated
+1.15%
SYRE - FOLD
40%
Loosely correlated
+1.82%
ROIV - FOLD
40%
Loosely correlated
+7.72%
More